Stockreport

BioCardia anticipates Japan PMDA review and FDA meeting request on CardiAMP in Q4 2025 while advancing clinical programs [Seeking Alpha]

BioCardia, Inc.  (BCDA) 
PDF CEO Peter Altman provided updates on regulatory progress for CardiAMP cell therapy targeting ischemic heart failure, noting, "we have been working on regulatory submiss [Read more]